Literature DB >> 19878317

In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.

Na Guo1, Xiuping Wu, Lu Yu, Jingbo Liu, Rizeng Meng, Jing Jin, Huijun Lu, Xuelin Wang, Shuhan Yan, Xuming Deng.   

Abstract

A checkerboard microdilution method, performed according to the recommendations of the National Committee for Clinical Laboratory Standards, was used to study the in vitro interaction of fluconazole and allicin in 24 fluconazole-resistant clinical isolates of Candida albicans, one experimentally induced strain S-1, and one ATCC type strain 10231. The interaction intensity was determined by spectrophotometric methods and visual reading of the checkerboard assay, and the nature of the interactions was assessed using two nonparametric approaches [fractional inhibitory concentration index (FICI) and DeltaE models]. Synergism was observed in 23 strains using FICI, and in 22 strains using DeltaE. The DeltaE model gave results consistent with FICI, but no antagonistic action was observed. The positive interactions were also confirmed by the time-killing test and agar diffusion in the selected strains. Moreover, the in vivo experiment showed that a combination of fluconazole and allicin exhibited a good synergism against C. albicans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878317     DOI: 10.1111/j.1574-695X.2009.00620.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

Review 1.  Antifungal adjuvants: Preserving and extending the antifungal arsenal.

Authors:  Arielle Butts; Glen E Palmer; P David Rogers
Journal:  Virulence       Date:  2016-07-26       Impact factor: 5.882

2.  Cobalt Bis-Dicarbollide Enhances Antibiotics Action towards Staphylococcus epidermidis Planktonic Growth Due to Cell Envelopes Disruption.

Authors:  Eva Vaňková; Kristýna Lokočová; Petra Kašparová; Romana Hadravová; Ivana Křížová; Olga Maťátková; Jan Masák; Václav Šícha
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-26

3.  Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans.

Authors:  Awanish Kumar; Sanjiveeni Dhamgaye; Indresh Kumar Maurya; Ashutosh Singh; Monika Sharma; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

4.  Lipidome analysis reveals antifungal polyphenol curcumin affects membrane lipid homeostasis.

Authors:  Monika Sharma; Sanjiveeni Dhamgaye; Ashutosh Singh; Rajendra Prasad
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

5.  Chemosensitization as a means to augment commercial antifungal agents.

Authors:  Bruce C Campbell; Kathleen L Chan; Jong H Kim
Journal:  Front Microbiol       Date:  2012-02-29       Impact factor: 5.640

6.  Quantitative and qualitative analysis of the antifungal activity of allicin alone and in combination with antifungal drugs.

Authors:  Young-Sun Kim; Kyung Sook Kim; Ihn Han; Mi-Hyun Kim; Min Hyung Jung; Hun-Kuk Park
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

7.  Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis.

Authors:  Jing Jin; Ji-Yu Zhang; Na Guo; Hui Sheng; Lei Li; Jun-Chao Liang; Xue-Lin Wang; Yang Li; Ming-Yuan Liu; Xiu-Ping Wu; Lu Yu
Journal:  Molecules       Date:  2010-10-29       Impact factor: 4.411

8.  Antibacterial and Antifungal Activity of Propyl-Propane-Thiosulfinate and Propyl-Propane-Thiosulfonate, Two Organosulfur Compounds from Allium cepa: In Vitro Antimicrobial Effect via the Gas Phase.

Authors:  Antonio Sorlozano-Puerto; Maria Albertuz-Crespo; Isaac Lopez-Machado; Lidia Gil-Martinez; Juan Jose Ariza-Romero; Alba Maroto-Tello; Alberto Baños-Arjona; Jose Gutierrez-Fernandez
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-29

9.  In vitro Activity of Allicin Alone and in Combination With Antifungal Drugs Against Microsporum canis Isolated From Patients With Tinea Capitis.

Authors:  Ya Bin Zhou; Yuan Yuan Xiao; Jin Jing Chao; Lin Ma
Journal:  Front Med (Lausanne)       Date:  2021-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.